CCDS-O Certified Clinical Documentation Specialist-Outpatient (CCDS-O) Questions and Answers

CDI staff do not alter the legal health record and should not “code it as is” when documentation is unclear, conflicting, or incomplete in a way that impacts accurate reporting. The compliant next step is to issue a provider query for clarification, ensuring the final record accurately reflects the provider’s clinical judgment. ACDIS-guided outpatient CDI emphasizes that queries are a quality and compliance tool: they reconcile discrepancies (e.g., conflicting diagnoses across notes, missing linkage between symptoms and conditions, unclear acuity such as “CHF” without type/status, or ambiguous infection documentation). The query should be supported by clinical indicators from the chart and should ask the provider to document the clarified diagnosis/status in the record (progress note, addendum, or appropriate attestation). Escalation to compliance is reserved for patterns of nonresponse, suspected integrity concerns, or systemic issues, not routine discrepancies. The objective is to achieve a complete, consistent clinical story that supports coding, risk adjustment, quality reporting, and medical necessity—through provider clarification, not CDI edits.

Home oxygen is a strong clinical indicator, but by itself it does not tellwhythe patient requires it. Outpatient CDI best practice prioritizes clarifying theclinical indicationbecause it drives accurate, compliant diagnosis reporting and supports medical necessity and severity of illness. “Oxygen dependence” (a status concept) may be appropriate, but it is secondary and often incomplete without the underlying condition—such aschronic hypoxic respiratory failure,chronic respiratory failure with hypercapnia, or persistent hypoxemia related to end-stage COPD/emphysema. Clarifying the indication also helps ensure the provider documents objective support (e.g., qualifying O2 sats, ABG findings, exertional vs resting hypoxemia) and ties it to assessment/plan at the PCP visit. While specifying heart failure type (A) is valuable, and emphysema “status” (B) may be less actionable because emphysema is typically chronic and encompassed within COPD management, the oxygen requirement is the most immediate cue of higher acuity and a frequent documentation gap. Therefore, clarifying the indication for home oxygen is the highest-value query opportunity.

In the CMS-HCC model, diabetes categories are hierarchical, meaning you capture the highest supported diabetes HCC for the year, not multiple diabetes HCCs simultaneously. Type 2 diabetes with peripheral neuropathy represents achronic diabetic complication, so it maps toHCC 18 (Diabetes with Chronic Complications)rather than HCC 19 (without complications) or HCC 17 (acute complications). COPD is documented as present and clinically relevant (even without an exacerbation) and therefore maps toHCC 111 (Chronic Obstructive Pulmonary Disease)when it is assessed/managed as part of the visit. “History of depression, stable” does not necessarily meet the threshold forHCC 58, which is reserved for specific serious psychiatric diagnoses (e.g., major depressive disorder, bipolar disorder, paranoid disorders). A general “depression” history, especially if not specified as major depressive disorder and not actively addressed, often will not support HCC 58 capture. Therefore, the visit captures HCC 18 and HCC 111 only.

A core outpatient guideline difference is how to handle uncertainty in diagnoses. In the inpatient setting, facilities may code diagnoses documented as “probable,” “suspected,” “likely,” or “rule out” at discharge if they meet inpatient reporting rules. In outpatient/office settings, however, uncertain conditions generally are not coded as established diagnoses because the encounter is often focused on evaluation rather than confirmed final diagnoses. Instead, outpatient coding relies on confirmed conditions and/or signs and symptoms when a definitive diagnosis has not been made. This is why outpatient CDI education emphasizes precise provider language: if the clinician is still evaluating, they should document the symptom/abnormal finding and the assessment plan; if the condition is confirmed, they should state it clearly and link it to evaluation/management performed. Options A, B, and D are incorrect because chronic conditions may need to be reported whenever they are assessed/managed, “first-listed” is an outpatient concept distinct from inpatient “principal,” and documentation should support all clinically relevant conditions addressed, not only the chief complaint.

The documented clinical picture and treatment plan better align with pneumonia than uncomplicated bronchitis, creating a clear documentation/coding consistency opportunity. ALLL infiltrate on chest x-rayis a classic clinical indicator for pneumonia, and prescribinglevofloxacinsupports treatment of a likely bacterial lower respiratory infection rather than routine viral bronchitis. The patient also hasfever, dyspnea, cough, and required an in-officenebulizer treatment, all of which can accompany pneumonia and increase clinical significance. In outpatient CDI practice, the most appropriate query is the one that clarifies the provider’s definitive diagnosis when objective findings and management suggest a more specific condition than what is stated (e.g., “possible bronchitis”). Querying for diabetic complications or heart failure specificity is not as directly supported by the encounter’s indicators and treatment actions provided, and “acuity of bronchitis” is secondary if the true condition is pneumonia. Clarifying whether pneumonia is present ensures accurate reporting, medical necessity support, and appropriate risk/quality capture.

In outpatient CDI and coding education, selecting the correct E/M code starts with identifying theencounter category(e.g., office/outpatient vs inpatient/observation vs ED) and whether the patient isnew or established, because these define the applicable CPT code range. Next, thelevel of serviceis selected within that range based on the documentation supporting the required elements for that code family. For most E/M services, “site of service” (place/setting) and “new vs established” are foundational code-selection drivers, while “level” is determined by the record’s support for the applicable leveling methodology (commonly medical decision making and, when allowed/appropriate, time). Time can be a valid leveling method for many office/outpatient E/M visits, but it is not universally the basis for the majority of E/M services across all categories; it is an alternative pathway when documentation supports it. Physician specialty and patient age do not define the majority of E/M code selection. Therefore, the best overall statement is new/established status + site of service + level of service.

In outpatient CDI and coding guidance, an “uncertain diagnosis” is identified by wording that indicates the provider has not confirmed the condition (e.g., possible, probable, suspected, rule out, question of, concern for). These terms reflect diagnostic consideration rather than an established diagnosis. Option A uses the phrase “concern for,” which is a classic uncertainty qualifier and signals the provider is considering streptococcal pneumonia but has not definitively diagnosed it. In contrast, options B and D describe active treatment “for streptococcal pneumonia,” which implies the provider is managing the condition as a working diagnosis; however, in outpatient coding, treatment alone does not automatically make a diagnosis confirmed if the documentation still reflects uncertainty—CDI would look for explicit provider confirmation. Option C (“evidence of”) generally suggests supportive findings and is commonly interpreted as stronger than “concern for,” though CDI would still assess whether the provider has clearly stated a confirmed diagnosis in the assessment/plan. Therefore, the clearest uncertain descriptor is “concern for.”

ACOs commonly focus on strengthening documentation and coding of clinically relevant chronic conditions because many quality and utilization comparisons—including readmission-related performance assessments—are influenced by patient complexity and risk adjustment. When chronic diseases and their specificity (e.g., stage, severity, manifestations) are under-documented, attributed patients can appear “healthier” on paper than they truly are, which can worsen an organization’s apparent readmission performance when outcomes are compared to an expected benchmark. Provider education that reinforces documenting active conditions that are monitored, evaluated, assessed/addressed, or treated helps ensure an accurate picture of acuity and comorbidity burden. This improves the integrity of risk adjustment inputs and supports fairer benchmarking, while also strengthening medical necessity and continuity-of-care communication across settings. The other choices represent either noncompliant behavior (avoiding condition reporting), poor documentation practice (promoting unspecified codes), or operational maneuvering that may be perceived as gaming rather than a sustainable quality strategy. Therefore, educating providers to capture chronic conditions accurately is the best and most commonly used improvement approach.

For outpatient Evaluation and Management (E/M) services, “medical necessity” is ultimately judged against Medicare coverage policy, which is established through National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). NCDs set nationwide rules for when specific services are considered reasonable and necessary, while LCDs are developed by Medicare Administrative Contractors to define coverage expectations within their jurisdictions, including indications, frequency limits, required documentation elements, and diagnosis-to-service relationships. Outpatient CDI and coding education emphasizes that correct E/M code selection and documentation must support not only the level of service (MDM/time) but also why the service was needed based on the patient’s condition and the payer’s coverage criteria. Specialty society recommendations and AMA/AHA guidance can inform clinical practice and coding conventions, but they do not define Medicare coverage requirements. Likewise, AHIMA provides professional guidance but does not set payer medical necessity policy. Therefore, the most accurate source defining medical necessity criteria for billing compliance is NCDs and LCDs.

Effective outpatient CDI depends on provider engagement, efficient workflows, and respectful communication. When a provider is frustrated about time pressures, the most productive approach is to partner with them to reduce friction while preserving compliant documentation improvement. ACDIS outpatient CDI concepts emphasize collaboration and provider education—meeting the provider where they are, understanding their workflow constraints, and jointly designing a query process that is minimally disruptive (e.g., batching queries, aligning with clinic schedules, using prospective queries, leveraging templates, or routing through agreed channels). Option C directly addresses the root issue (workflow burden) and builds trust by seeking the provider’s input and scheduling the discussion at their convenience. Option A is confrontational and frames CDI as a compliance demand rather than a clinical accuracy initiative. Option B is inappropriate because CDI cannot stop querying when clarification is needed for accurate documentation, coding, quality reporting, and risk adjustment. Option D escalates prematurely and damages relationships; escalation is typically reserved for persistent, unresolved non-responsiveness after collaborative efforts and leadership-supported education.

Outpatient CDI queries are most commonly triggered when there is a disconnect between the documented diagnosis and the documented treatment plan, suggesting that the clinician may be managing an additional condition that is not clearly stated, or that the diagnosis is inaccurately documented. Options A and B reflect typical, clinically aligned management: luteinizing hormone-releasing hormone therapy is a standard treatment pathway for prostate carcinoma, and amiodarone is a recognized antiarrhythmic used in atrial fibrillation management in appropriate circumstances. Option C can also be clinically consistent because parenteral nutrition is often used when malnutrition is present and the patient cannot meet nutritional needs enterally. Option D is the outlier: “immunotherapy” is not a standard treatment for severe major depressive disorder and more commonly aligns with oncology or certain immune-mediated diseases. This mismatch would appropriately prompt a query to clarify the actual condition being treated (e.g., an active malignancy) or to confirm whether “immunotherapy” refers to something else (such as allergy immunotherapy) and whether depression is the correct, visit-relevant diagnosis being addressed.

In the outpatient setting, when the provider does not document a definitive diagnosis for the acute complaint (e.g., influenza, sinusitis, URI), ICD-10-CM guidance directs coders to report thesigns and symptomsthat are documented and addressed. Here, the clinician documentscongestion, fever, and malaiseand provides treatment instructions for those symptoms (OTC meds, rest, follow-up). That makes the symptom codes the most appropriate representation of the reason for the encounter. Outpatient CDI principles further emphasize that chronic conditions likeDM, GERD, and HTNshould only be coded when the documentation shows they wereevaluated, monitored, assessed/managed, or treatedduring the visit (e.g., status, control, medication adjustment, related testing, counseling). In this note, the plan targets only the acute symptoms and does not demonstrate active management of the chronic conditions beyond listing history/medications. Therefore, the guideline most directly applicable to correct coding of the encounter iscodes that describe symptoms and signs.

Medicaid risk adjustment models generally calculate risk using two major categories of inputs:demographicsanddiagnosis data. Demographic factors commonly includegenderand indicators tied toMedicaid status/eligibility(for example, eligibility category, dual status, disability-related eligibility, or other program qualifiers depending on the state/model). These demographic elements adjust expected cost and are foundational to the risk score even before considering diagnoses. By contrast,race is not a standard inputfor calculating Medicaid risk scores in typical risk adjustment methodologies, so options that include race are not supported. Likewise, “patient noncompliance” is primarily a clinical and quality-of-care issue and may affect treatment outcomes, but it isnot itself a standard risk-score driverunless it is documented as a reportable, supported diagnosis that the specific model recognizes (and most models don’t directly risk-adjust for nonadherence codes). Therefore, among the options given,Medicaid status and genderare the most clearly valid factors that impact the beneficiary’s risk score.

In hospital outpatient settings paid under OPPS, Ambulatory Payment Classifications (APCs) are influenced by the coded services and, in many workflows, the clinical documentation that supports correct CPT/HCPCS selection, units, modifiers, and—when applicable—medical necessity linkages to diagnoses. Accurate documentation ensures that the record supports what was actually performed (e.g., complexity, laterality, supplies, drug administration details, observation criteria, or separately payable procedures) and that coding can correctly apply bundling/packaging rules without losing legitimately reportable services. While APCs are primarily procedure-driven, documentation remains decisive because incomplete or ambiguous notes lead to downcoding, missed charges, incorrect status indicators, or denials during medical review. From an outpatient CDI standpoint, the goal is to ensure the clinical story supports codeable services and their necessity: clear indications, findings, assessment/plan, and any required elements (time, start/stop, dose/route for medications, device details, etc.). This supports appropriate APC grouping and reimbursement integrity, reducing rework, denials, and compliance risk.

The clinical indicators strongly supportalcohol dependence, not merely alcohol “use” or “abuse.” The patient reports heavy, compulsive intake (early-morning drinking and at least a pint daily), and the provider explicitly documents that she “continues to be dependent on alcohol” and discusses treatment options—this aligns with a dependence-level disorder being addressed.Hypertensionis also supported because the BP is elevated (165/89) and the provider documents management activity (medications and diet counseling), meeting encounter relevance/reportability expectations.Diabetesis listed among chronic conditions, but the scenario provides no indicators of complications (no neuropathy, CKD, ulcers, retinopathy, etc.), so the supported choice is DM type 2without complicationsrather than “with complications.” Although COPD is listed in the “including” statement, no COPD-specific assessment/monitoring/treatment is described in the indicators provided, so the best-supported grouped option focuses on the conditions with clear supporting indicators and management in the note: DM2 without complications, HTN, and alcohol dependence.

RAF (Risk Adjustment Factor) is best explained to providers as a population-health and resource-planning tool, not a visit-level payment lever. In outpatient risk adjustment models, diagnoses and demographics are used to estimate the patient’s overall disease burden and the expected cost/resources required to meet that patient’s healthcare needs. When documentation accurately reflects active conditions and their specificity, the patient’s risk profile is represented more realistically. That improves care in practical ways: it supports appropriate allocation of care management services (e.g., nurse navigators, chronic care programs), helps organizations anticipate medication, testing, specialist, and follow-up needs, and improves fairness of performance benchmarking by comparing outcomes and costs against similarly complex patients. Option A is overly simplistic because RAF does not directly determine an individual provider’s reimbursement for a given encounter; it influences broader payment and benchmarking methodologies tied to attributed populations. Option C is not what RAF measures, and option D confuses RAF with medical necessity, which is based on clinical documentation and coverage rules, not a risk score.

In obstetric and postpartum coding, the most important clarification is thetype/timingof hypertension because ICD-10-CM has distinct categories for chronic (pre-existing) hypertension, gestational hypertension, and hypertensive disorders that persist into or present during the postpartum period. At 6 weeks postpartum with elevated readings (including a systolic of 160) and headache, the documentation “hypertension” is not specific enough to determine whether this represents chronic hypertension that predates pregnancy, gestational hypertension that has not resolved, or another pregnancy-related hypertensive disorder requiring different obstetric coding and follow-up. ACDIS outpatient CDI guidance prioritizes queries that resolve coding-impactful ambiguity using clinically supported options without leading the provider. While postpartum preeclampsia could be a clinical consideration, the note does not provide key supporting elements (e.g., proteinuria or other definitive severe-feature criteria), so jumping directly to preeclampsia/eclampsia is less appropriate than clarifying onset and relationship to pregnancy. Linking hypertension to smoking is not a standard required linkage for diagnosis coding, and “hypertensive crisis” is not supported by the documentation provided.

This question applies the outpatient risk adjustment “reserve” concept: predicted cost is estimated by multiplying the member’s risk factor contribution by a baseline per-member-per-month (PMPM) amount, then annualizing. The morbid obesity HCC factor is 0.186, and PMPM is $800. First compute the monthly cost impact: $800 × 0.186 = $148.80 per month per patient. Convert to yearly: $148.80 × 12 = $1,785.60 per patient per year. The year-over-year increase in patients with morbid obesity documentation is 11,000 − 10,000 = 1,000 additional patients. Multiply the annual per-patient impact by the additional patient count: $1,785.60 × 1,000 = $1,785,600. Outpatient CDI programs emphasize that improving documentation specificity (when clinically supported) can change whether an HCC is captured, which can affect RAF-based projections and resource planning. However, documentation must still be accurate, supported, and reflect conditions assessed/managed during the encounter.

Outpatient CDI programs should share provider-facing metrics that are clinically meaningful, aligned with ambulatory documentation goals, and unlikely to be perceived as payment-driven prompting.RAF scoresare an appropriate metric because they reflect how well the documented and coded condition burden represents the patient panel’s complexity in risk adjustment models. Discussing RAF supports education around accurate diagnosis capture, specificity, and annual recapture of active chronic conditions that are monitored, evaluated, assessed/addressed, or treated. In contrast,APC payment ratesare facility OPPS payment constructs and typically are not actionable for individual ambulatory provider documentation improvement.HCC per member per month paymentsis explicitly financial and can create compliance risk by tying documentation discussions directly to payment, which outpatient CDI guidance warns against in provider messaging.MCC ratesare primarily an inpatient DRG severity concept and are not the most relevant outpatient performance measure. Therefore, RAF scores best balance provider relevance, program goals, and compliant education focus.

A compliant prospective query is initiated before the next encounter so the provider can clarify documentation during the upcoming visit, using clinically relevant indicators without directing a specific diagnosis. Option A does this appropriately: it references an existing CHF history and a supportive medication (Lasix), then asks the provider to confirm whether CHF is pertinent at the next visit and, if so, to specify type and acuity. This supports accurate outpatient reporting because heart failure coding requires specificity (systolic/diastolic/combined; acute/chronic/acute on chronic) and should reflect what is actually evaluated/managed at the encounter. Option B is retrospective and attempts to justify a prior test. Option C is leading because it asks the provider to “add” a diagnosis to a past note rather than clarify current clinical status. Option D is also retrospective and uses “please add CHF,” which is leading and can be perceived as prompting. Therefore, A best demonstrates a compliant prospective query.

In outpatient CDI, diagnoses reported for an encounter must be supported as current and clinically relevant to that visit (evaluated, monitored, assessed, treated, or otherwise affecting care). The note documents ahistoryof sick sinus syndrome with pacemaker placement in 2016 and indicates the current rhythm ispaced. The most clearly reportable, present condition is thepresence of a cardiac pacemaker, which is a status that can affect clinical decision-making (e.g., interpretation of rhythm findings, medication choices, procedures, and future cardiac evaluation) and is appropriate to code when documented. However, the documentation does not show that sick sinus syndrome itself was actively assessed or managed during this visit; it is referenced as a past condition leading to the device. Because outpatient coding does not assume an active diagnosis solely from historical mention, the best action is to capture thepacemaker statuscode only. Retrospective amendment requests or rebilling steps are not the first-line CDI action when the documentation does not support active management of the underlying arrhythmia.

The patient’s RAF is calculated by adding the applicable HCC weights plus the demographic factor, but only after applying the HCC model’s hierarchy rules. In outpatient risk adjustment education (as emphasized in ACDIS-based training), certain condition groups are hierarchical—meaning multiple related diagnoses in the same hierarchy do not “stack.” Instead, only the highest-ranked HCC in that disease group contributes to the RAF. Here, “diabetes with nephropathy” and “diabetes with retinopathy” both carry the same HCC weight (0.166) and fall within the diabetes complication hierarchy, so they do not add together; only one 0.166 value is counted. Atrial fibrillation contributes separately (0.299), and the demographic risk factor contributes (0.332). Therefore, the final RAF is 0.166 + 0.299 + 0.332 = 0.797. This illustrates why outpatient CDI focuses on documenting all clinically supported conditions for care accuracy, while understanding that some related diagnoses won’t increase RAF beyond the highest applicable HCC in that hierarchy.

In the outpatient/ambulatory setting, ICD-10-CM reporting rules applied in CDI education distinguish clearly between confirmed diagnoses and “uncertain” or “rule out” conditions. Terms such as “rule out,” “suspected,” or “probable” generally are not coded as established diagnoses in the outpatient record because the encounter is often for evaluation and testing rather than definitive confirmation. Instead, coders report the patient’s presenting signs and symptoms when a definitive condition has not been documented as confirmed by the provider. Here, the clinician ordered diagnostic testing (ECG and chest x-ray) specifically to rule out myocardial infarction (MI), but no final diagnosis of MI or angina is documented in the scenario. Therefore, “rule out MI” is not reportable, and neither is acute MI or angina unless explicitly diagnosed. The reportable conditions are the symptoms that drove the visit and required evaluation: chest pain (captured as “other chest pain” in the options), shortness of breath, and nausea.

Under the CMS-HCC risk adjustment methodology, the RAF is calculated primarily from two categories of inputs: (1) demographic/enrollment eligibility factors and (2) diagnosis codes that map to HCCs based on documented, reportable conditions. Eligibility status matters because Medicare models differentiate beneficiaries by factors such as aged versus disabled status and other enrollment characteristics that affect expected cost. The second major driver is the set of valid, supported ICD-10-CM codes reported for the beneficiary during the data collection period; only certain chronic, clinically significant conditions map to HCCs, and they must be documented as active and applicable to the encounter and coded correctly. In ambulatory CDI, this is why accurate condition capture, specificity, and linkage (e.g., cause/manifestation relationships) are emphasized—because reported conditions directly affect the patient’s risk profile and the expected cost benchmark. By contrast, income status is not a standard CMS-HCC input, “previous risk score” is not itself an input variable, and utilization outcomes like cost of care or readmissions are not used to compute RAF (they may be evaluated separately in quality/cost programs).

Sertraline is a selective serotonin reuptake inhibitor (SSRI) most commonly used to treat depressive disorders and several anxiety-related conditions. In outpatient chart review, recognizing medication–condition relationships supports accurate problem list maintenance and compliant diagnosis reporting, but the diagnosis must still be clearly documented as assessed/managed at the encounter. Depression is the best match because SSRIs like sertraline are first-line pharmacologic therapy for major depressive disorder and are frequently continued long-term with monitoring for symptom control, side effects, and functional status. Schizophrenia is primarily treated with antipsychotic medications; sertraline may be used only as an adjunct if a comorbid depressive or anxiety disorder is present, so it is not the common primary treatment. Asthma management centers on bronchodilators and inhaled corticosteroids, not SSRIs. Heart failure therapy involves guideline-directed cardiac medications (e.g., beta-blockers, ACE inhibitors/ARNI, diuretics), and sertraline is not a standard heart failure treatment. Outpatient CDI education emphasizes documenting the specific mental health diagnosis, current status (stable/worsening), and treatment plan to support coding.

The definition in option B is the official Uniform Hospital Discharge Data Set (UHDDS) definition used for inpatient coding: the principal diagnosis is the condition determined—after evaluation—to be chiefly responsible for the admission. It is not simply the first condition written, nor necessarily the “worst” or most severe condition; it is the reason for admission once the workup clarifies the clinical picture. CDI practice reinforces this because principal diagnosis selection drives DRG assignment, quality metrics, and reporting, and errors often stem from confusing presenting symptoms with the final established diagnosis. Although outpatient settings use different concepts (e.g., first-listed diagnosis for the encounter), ACDIS education frequently contrasts inpatient “principal diagnosis” with outpatient “first-listed” to prevent documentation and coding misalignment. Clinicians should document the definitive condition when known (and link symptoms to that condition), and clearly describe diagnostic uncertainty when not yet established. This clarity supports compliant coding, accurate benchmarking, and defensible medical necessity across settings.

CDI education focused on diagnosis specificity and complete, clinically supported documentation most directly influences theQualityandCostperformance categories. In the Quality category, many measures depend on correct identification of eligible patient populations (denominators), exclusions, and risk adjustment. When providers document conditions precisely (e.g., specific heart failure type, diabetes complications, CKD stage), it improves the accuracy of coded data that underpins measure calculations and risk stratification. In the Cost category, CMS uses claims-based methodologies that compare observed versus expected costs; accurate diagnosis capture affects patient complexity and risk adjustment, which can materially change expected cost targets and episode attribution. ACDIS outpatient CDI principles emphasize that incomplete or vague documentation can make patients appear less complex than they are, potentially worsening both quality comparisons and cost benchmarks. By contrast, Promoting Interoperability is driven primarily by EHR use and electronic processes, and Improvement Activities reflect practice transformation/engagement rather than diagnosis specificity. Therefore, Quality and Cost are the MIPS categories most impacted by CDI education on specificity.

In outpatient CDI chart review, a key skill is recognizing when medications and treatment plans suggest a specific diabetic complication that is not explicitly documented. Gabapentin is commonly prescribed for neuropathic pain, and in a diabetic patient it is frequently used to treatdiabetic peripheral neuropathysymptoms (burning, tingling, numbness, shooting pain). ACDIS outpatient CDI guidance supports querying when there are strong clinical indicators that a more specific, clinically relevant diagnosis may be present and is being treated at the encounter, because diabetes codes require complication specificity when supported (e.g., “diabetes with neuropathy” rather than unspecified diabetes). The elevated glucose and A1C confirm ongoing diabetes management but do not, by themselves, indicate CKD, macular degeneration, or ketoacidosis. Ketoacidosis would require documentation of acute metabolic decompensation and supporting clinical/lab findings, which are not provided here. Therefore, the most appropriate clarification is whether the patient has diabetic peripheral neuropathy (and whether it is painful neuropathy) being managed with gabapentin, so the provider can document the condition clearly and accurately.

In ambulatory CDI chart review, clinical indicators should align with assessment and management captured in the note (problem relevance and MEAT-style support: monitor, evaluate, assess/address, treat). This visit has two strong indicators that warrant medication evaluation. First, dyspnea plus a rapid 10-lb weight increase over two weeks is a classic signal of possible fluid overload in a patient with heart failure, making a loop diuretic such as Lasix clinically relevant to assess (effectiveness, adherence, dose changes, exacerbation risk, and whether HF is stable vs decompensated). Second, the A1c has worsened significantly (9.2 from 7.2), indicating inadequate glycemic control that should prompt review and adjustment of diabetes therapy; insulin such as NovoLog is directly tied to diabetes treatment escalation or optimization. The other medication pairs do not logically match the documented problems and indicators (e.g., appetite stimulant/anemia therapy, immunosuppressant, antidepressant/antihistamine). Therefore, NovoLog and Lasix best reflect what should be evaluated and addressed

The CMS-HCC model is arisk adjustmentmethodology used primarily to setcapitated paymentsfor Medicare Advantage (MA) organizations based on the expected cost of caring for their enrolled beneficiaries. Under this approach, CMS calculates a Risk Adjustment Factor (RAF) for each member using demographic variables (such as age/sex and certain entitlement factors) plus disease burden captured from ICD-10-CM diagnoses that map to Hierarchical Condition Categories (HCCs). The resulting RAF increases or decreases the plan’s payment to better match predicted healthcare needs—higher RAF for sicker, more complex patients and lower RAF for healthier patients. ACDIS outpatient CDI education emphasizes that the purpose is not physician reimbursement based on a “principal diagnosis” (an inpatient concept) and not payment distribution tied directly to quality performance (that aligns more with MIPS/VBP frameworks). It also does not adjust capitation payments specifically “to physicians,” nor does it exclude advanced practice providers in the way described. The correct use is todetermine MA plan capitation paymentsthrough risk-adjusted member-level projections.

Nightly reliance on CPAP in a morbidly obese patient most strongly points to sleep-disordered breathing, and in the context of severe obesity (BMI 45), it raises concern forobesity hypoventilation syndrome (OHS), which is characterized byalveolar hypoventilation(chronic hypoventilation with hypercapnia) that is not fully explained by other pulmonary or neuromuscular causes. While CPAP is commonly prescribed for obstructive sleep apnea, severe obesity increases the likelihood of associated hypoventilation physiology; in outpatient CDI review, this becomes a documentation opportunity to ensure the provider specifies whether the patient has OSA alone versus OSA with OHS/alveolar hypoventilation, because the latter reflects higher clinical complexity and requires clear monitoring/management (e.g., ABGs or bicarbonate trends, symptoms of hypoventilation, adherence, need for BiPAP). Heart failure and pulmonary edema are not implied by CPAP use, and essential hypertension is common in obesity but not the condition most specifically linked to CPAP dependence. Therefore, alveolar hypoventilation is the best supported answer.

A high query rate with a strong physician response rate shows the CDI specialist is generating many queries and providers are opening/responding to them. However, a consistently lowagree rateindicates providers frequently select “disagree,” “clinically undetermined,” or otherwise do not validate the query’s suggested clarification. In outpatient CDI program management, that pattern most often reflectsquery quality problems—for example, queries that are not well-supported by encounter-specific clinical indicators, queries that are vague or overly speculative, or queries that do not align with outpatient reportability standards (e.g., prompting for diagnoses not clearly monitored/evaluated/assessed/treated). While leading queries are a compliance concern, the more direct operational inference from “high volume + answered + not agreed with” is that the queries are not clinically compelling or are poorly constructed, resulting in frequent provider non-concurrence. Case complexity alone would not reliably drive low agree rates if the queries were appropriately targeted and evidence-based. Therefore, the most likely interpretation is poor-quality queries requiring coaching on clinical support, clarity, and compliant construction.

In MSSP-style ACO financial reconciliation, performance is evaluated against a benchmark (expected costs). Here, the ACO’s actual spending ($52M) exceeds the expected benchmark ($50M) by $2M, meaning the ACO generatedshared lossesrather than savings. In risk-bearing ACO arrangements, when costs exceed the benchmark and the ACO is in a track that includes downside risk, the organization may owe CMS a portion of those losses. The shared savings/loss rate (50% in this scenario) represents the percentage of the difference from the benchmark that the ACO shares with CMS, assuming applicable thresholds are met. Thus, instead of receiving a shared savings payment, the ACO would be accountable topay backa share of the excess spending (conceptually 50% of the $2M overage, if all model requirements are satisfied). Option D is not correct because reconciliation is typically performed on a performance-year basis rather than only at the end of the full agreement period, and option C is not how MSSP eligibility works.

In outpatient CDI,MEATis a commonly taught framework used to determine whether a condition is sufficiently supported asreportablefor a specific encounter. MEAT stands forMonitor, Evaluate, Assess/Address, and Treat. The concept is that diagnoses should not simply be copied forward on a problem list; they should be tied to provider work and clinical relevance during the visit. “Monitor” includes reviewing status, trends, or test results related to the condition. “Evaluate” includes ordering or interpreting studies, considering disease progression, or documenting response to therapy. “Assess/Address” includes documenting stability, exacerbation, or risk and making a plan (education, counseling, referrals). “Treat” includes medications, procedures, or other therapeutic interventions. Using MEAT helps CDI staff educate providers to document thecurrent statusand management of chronic diseases, supports accurate coding and risk adjustment, and reduces denials by showing medical necessity. OPPS, MACRA, and RADV are important regulatory/payment terms, but they are not the standard acronym used to assess encounter-level reportability.

The documentation shows a patient with advanced COPD (GOLD stage 3) who now requires an increase in home oxygen to 3 liters, along with escalation of respiratory therapies (home nebulizers and systemic steroids). In outpatient CDI, an increased or ongoing home oxygen requirement is a strong clinical indicator that the provider may be managingchronic respiratory failure(or chronic hypoxemic respiratory failure), which is more clinically meaningful than simply documenting oxygen use as a status. “Oxygen dependence” is a status code and does not fully describe the underlying physiologic impairment driving the need for oxygen; chronic respiratory failure captures the severity and ongoing nature of the condition and better reflects risk, complexity, and medical necessity for durable oxygen therapy. Querying for pneumonia organism specificity is not as relevant in a follow-up visit unless pneumonia is still being actively treated and the organism is known. Querying COPD acuity (e.g., exacerbation) may be appropriate, but the most significant clarification prompted by increased home O2 is whether chronic respiratory failure is present and being managed.

In outpatient CDI, a strong specificity opportunity is to clarify the exactdiagnostic termthat best matches clinical indicators and supports correct ICD-10-CM reporting. The patient has multiple depressive symptoms (weight loss, poor appetite, low energy, impaired concentration), is already treated with an antidepressant (paroxetine), and has aPHQ-9 score of 11, consistent with at least moderate depressive symptom burden that warrants diagnostic clarity. Among the options, onlyMajor Depressive Disorder (MDD)is a recognized clinical diagnosis category with structured ICD-10-CM options that require further specificity (e.g., single vs recurrent episode, severity—mild/moderate/severe, psychotic features, and remission status). The other choices (“occurrence,” “event,” “reaction”) are nonspecific, nonstandard phrases that do not reliably map to accurate ICD-10-CM diagnostic reporting and do not help improve documentation precision. A compliant query would ask the provider to specify whether the patient hasMDDand, if so, document the episode type/severity and relationship to insomnia if clinically relevant, ensuring the record reflects what is being evaluated and treated during the encounter.

A compliant query is designed to clarify the record without steering the provider to a predetermined answer. ACDIS-aligned standards stress two essentials: neutrality (non-leading phrasing) and clinical support (relevant indicators). Clinical indicators might include vitals, labs, imaging, medications, documented symptoms, problem list history, or assessment findings that create the need for clarification. The query should present the inconsistency or ambiguity, reference the supporting facts, and offer clinically reasonable answer choices including “other” and “unable to determine” when appropriate. This structure protects documentation integrity and reduces regulatory risk, because leading queries can be interpreted as directing documentation for payment rather than accuracy. Verbal-only queries are not sufficient when they affect coding; CDI programs typically require a documented query trail per policy. Purely open-ended questions without context are also problematic because they do not show why clarification is needed and may not be actionable. Proper non-leading, indicator-supported queries improve accuracy of diagnosis specificity, severity capture, and defensibility in audits while preserving provider autonomy.

In the outpatient setting, thefirst-listed diagnosisis the condition chiefly responsible for the services provided during the encounter. Here, the stated reason for the visit iscontinued confusion and poor memory, and the provider specifically evaluates the patient’scurrent mental stateand references neurology consultation notes—actions that directly support assessment of a cognitive disorder. While HTN, GERD, and Parkinson’s are also addressed and may be reportable if they meet encounter relevance (e.g., monitored, evaluated, assessed/managed, or treated), they are not the primary driver for today’s visit based on the presenting complaint. Outpatient documentation and coding guidance emphasizes sequencing the diagnosis that best explains the visit’s main purpose first, with additional coexisting conditions listed afterward when they impact care. Since “dementia” is on the active problem list and aligns with the patient’s cognitive symptoms and the physician’s mental-status evaluation, it is the most appropriate first-listed diagnosis among the options.

For reporting Evaluation and Management (E/M) services, the longstanding “key components” framework recognizeshistory, examination, and medical decision making (MDM)as the core elements used to determine the appropriate E/M level when the service is not reported based on time. In outpatient CDI education aligned with ACDIS concepts, MDM is emphasized because it reflects the clinician’s cognitive work and risk-based thinking: the complexity of problems addressed, the amount/complexity of data reviewed and analyzed (labs, imaging, external notes, independent interpretation), and the risk of complications and/or morbidity from additional testing or treatment. “Review of systems” is a sub-element of the history component, not a separate key component. “Nature of presenting problem” and “coordination of care” can be clinically relevant and may support medical necessity or time-based billing (when documented appropriately), but they are not one of the three key components that define E/M reporting structure. Therefore, the best answer is Medical decision making.